Oesophageal cancer is a global health problem; in 2018 there were more than 572,000
people newly diagnosed with oesophageal cancer worldwide. There are two main …

Gastroesophageal reflux disease (GERD) is a condition in which gastric contents regurgitate
into the esophagus or beyond, resulting in either troublesome symptoms or complications …

Summary Background Treatment of dysplastic Barrett's oesophagus prevents progression to
adenocarcinoma; however, the optimal diagnostic strategy for Barrett's oesophagus is …

This document is the official American Society for Gastrointestinal Endoscopy guideline on
screening and surveillance in patients with Barrett's esophagus (BE) and is based on …

Objective: The aim of this article was to study the prevalence and significance of sarcopenia
in the multimodal management of locally advanced esophageal cancer (LAEC), and to …

Since the early 1970s, the incidence of oesophageal adenocarcinoma has increased
dramatically in most Western populations. In contrast, the incidence of oesophageal …

The care of patients with oesophageal cancer or of individuals who have an elevated risk of
oesophageal cancer has changed dramatically. The epidemiology of squamous cell and …

Background & Aims Guidelines recommend endoscopic surveillance of patients with
Barrett's esophagus (BE) to identify those with dysplasia (a precursor of carcinoma) or early …

Background & Aims A proportion of patients with Barrett's esophagus (BE) are diagnosed
with esophageal adenocarcinoma (EAC) within 1 year of an endoscopic examination that …

Background & Aims Endoscopic surveillance of patients with Barrett's esophagus (BE) is
inefficient. Risk stratification of patients might improve the effectiveness of surveillance. We …